International Affairs
(Q300)
IRS Verified
DX Registered
990 on File
INTERNATIONAL AIDS VACCINE INITIATIVE INC
Financial strength (30%)
77/100
Reliability (20%)
55/100
Effectiveness (25%)
76/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$103.4M
Total Revenue
$107.3M
Total Expenses
$48.8M
Net Assets
239
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
85.2%
Fundraising Efficiency
N/A
Operating Reserve
5.45x
Liability-to-Asset
65.3%
Revenue Diversification
96.1%
Executive Compensation
$2.2M
Compared with Peers
FY 2025
Compared with 43 similar organizations
(United States, International Affairs, $100M and over in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
85.2% | 85.3% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
14.7% | 8.1% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.2% | 3.4% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
5.5 mo | 6.3 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
65.3% | 25.6% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
96.1% | 97.2% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-21.2% | 0.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-25.0% | -0.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-3.8% | 2.5% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $103.4M | $107.3M | $48.8M | 85.2% | 239 |
| 2024 | $131.2M | $143.0M | $51.4M | 88.9% | 260 |
| 2023 | $129.7M | $132.9M | $63.9M | 84.7% | 268 |
| 2022 | $146.8M | $131.2M | $66.3M | 89.4% | 245 |
| 2021 | $126.4M | $113.2M | N/A | — | 227 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.